All regulations
Rulemaking
FDA
RIN Not Assigned
FDA-2026-N-4643
Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device
Documents
1
Comments
0
Description
The Food and Drug Administration (FDA) is classifying the circulating tumor cell enrichment device into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the circulating tumor cell enrichment device. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients’ access to beneficial innovative devices, in part by reducing regulatory burdens.
Key Dates
Comment Period OpensMay 6, 2026
Documents
| Type | Title | Status |
|---|---|---|
Final Rule |
Keywords
CDRH
2026-111
Notice
Medical Devices
Immunology and Microbiology Devices
Classification of the Circulating
Tumor Cell Enrichment Device
OPEN
Data from Regulations.gov